Record Number of UF Faculty Earn National Science Foundation Awards
The National Science Foundation has recognized a record nine University of Florida faculty members from a wide variety of academic disciplines with 2022 Early Career Development Awards, one of its most prestigious honors.
New Research Identifies the Needs and Tools To Help Urban Farmers Succeed
The needs of commercial urban agriculture (CUA) operations in Florida have been relatively unknown, which led UF/IFAS researchers to dig deeper. A newly published study explains the most common challenges these farmers face and opportunities that could help them thrive.
Biochemist Studying How Cells Defend Against Viruses Joins UF Scripps Biomedical Research
A new scientist joining UF Scripps Biomedical Research, James M. Burke, Ph.D., is exploring how our innate immune system protects us from viruses — including the pandemic coronavirus — and how viruses evade these defenses.
What Does a Dog’s Nose Know? A.I. May Soon Tell Us
UF Accelerate client Canaery, thinks it can read the neurons firing in a dog’s olfactory bulb in real-time and, with the help of machine learning, turn the animal into a detection device able to suss out a vast range of molecules, all without the animal having to be specially trained. “This does for scent what machine vision did for sight,” says Gabriel Lavella, Canaery’s founder and chief executive officer.
Targeting a Human Protein To Squash SARS-CoV-2 and Other Viruses
More than two years into the COVID-19 pandemic, people are realizing that the “new normal” will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers are looking toward new strategies. In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
UF Health Designated Center of Excellence for Rare Inherited Condition Involving Blood Vessels
The Cure HHT foundation this month designated UF Health as Florida’s first HHT Center of Excellence and one of just 31 centers in North America, marking the health system as a top-tier provider of HHT treatment and research.
UF Health Names Lakesha Butler as Chief Diversity Officer
Lakesha Butler, Pharm.D., a professor of pharmacy practice and director of diversity, equity and inclusion at Southern Illinois University deeply trained in facilitating diversity-related discussion and policy change, has been named UF Health’s associate vice president for inclusion, diversity and health equity and chief diversity officer. She starts Aug. 22.
Leaders in Agriculture and Aerospace Partner To Create Rapid Crop Evaluation for Farmers
SATLANTIS LLC (SATLANTIS) and Agriculture Intelligence, Inc (AgIntel) announced a collaborative initiative with leading industry experts to combine agriculture intelligence and high resolution satellite monitoring with hopes to enhance current crop evaluation techniques for growers significantly. In late May, SATLANTIS successfully launched a satellite from the Cape Canaveral Force Station on board a SpaceX Falcon 9 rocket.
UF College of Pharmacy Moves Into Top 3 of National Research Rankings
The University of Florida College of Pharmacy moved up two places to No. 3 in the nation for total research funding in the latest American Association of Colleges of Pharmacy, or AACP, report released June 23. The No. 3 ranking is the highest ever achieved by the college when compared to peer institutions
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in the successful US and Global launch of Merck’s HPV/Gardasil Franchise. Ms. Murphy joined Oragenics’ Board of Directors in 2020.
